Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Uterine Cervical Neoplasms | 55 | 2012 | 1975 | 5.540 |
Why?
|
Papillomavirus Vaccines | 27 | 2012 | 486 | 4.910 |
Why?
|
Papillomavirus Infections | 37 | 2011 | 1516 | 4.160 |
Why?
|
Cost-Benefit Analysis | 101 | 2012 | 5268 | 2.790 |
Why?
|
Human papillomavirus 16 | 15 | 2011 | 269 | 2.680 |
Why?
|
Human papillomavirus 18 | 14 | 2011 | 128 | 2.630 |
Why?
|
Mass Screening | 42 | 2011 | 5214 | 2.400 |
Why?
|
Cervical Intraepithelial Neoplasia | 11 | 2010 | 307 | 1.880 |
Why?
|
Papillomaviridae | 15 | 2006 | 1144 | 1.620 |
Why?
|
Vaccination | 15 | 2013 | 2963 | 1.620 |
Why?
|
Quality-Adjusted Life Years | 37 | 2010 | 1616 | 1.490 |
Why?
|
Markov Chains | 21 | 2010 | 985 | 1.460 |
Why?
|
Tumor Virus Infections | 7 | 2004 | 457 | 1.200 |
Why?
|
Alphapapillomavirus | 5 | 2011 | 227 | 1.180 |
Why?
|
AIDS-Related Opportunistic Infections | 15 | 2007 | 656 | 1.140 |
Why?
|
Health Care Costs | 21 | 2012 | 3179 | 1.060 |
Why?
|
Helicobacter Infections | 4 | 2013 | 335 | 1.040 |
Why?
|
Developing Countries | 9 | 2013 | 2732 | 1.000 |
Why?
|
Helicobacter pylori | 4 | 2013 | 331 | 0.990 |
Why?
|
Vaginal Smears | 11 | 2011 | 502 | 0.990 |
Why?
|
Maternal Mortality | 3 | 2012 | 290 | 0.960 |
Why?
|
Models, Theoretical | 22 | 2013 | 3567 | 0.950 |
Why?
|
Rotavirus Vaccines | 4 | 2011 | 72 | 0.950 |
Why?
|
Rotavirus Infections | 4 | 2011 | 95 | 0.930 |
Why?
|
Stomach Neoplasms | 5 | 2013 | 1262 | 0.860 |
Why?
|
DNA, Viral | 14 | 2011 | 2293 | 0.850 |
Why?
|
Immunization Programs | 7 | 2010 | 276 | 0.770 |
Why?
|
Models, Economic | 10 | 2010 | 723 | 0.770 |
Why?
|
Models, Econometric | 10 | 2010 | 220 | 0.690 |
Why?
|
Anus Neoplasms | 5 | 2008 | 295 | 0.630 |
Why?
|
Colposcopy | 8 | 2008 | 143 | 0.600 |
Why?
|
Early Detection of Cancer | 6 | 2012 | 2943 | 0.580 |
Why?
|
Health Policy | 10 | 2008 | 2625 | 0.570 |
Why?
|
Decision Support Techniques | 9 | 2011 | 2043 | 0.570 |
Why?
|
HIV Infections | 32 | 2011 | 15673 | 0.560 |
Why?
|
Abortion, Induced | 2 | 2010 | 375 | 0.550 |
Why?
|
Sexually Transmitted Diseases, Viral | 2 | 2004 | 37 | 0.520 |
Why?
|
Computer Simulation | 19 | 2013 | 6100 | 0.510 |
Why?
|
Cost of Illness | 7 | 2008 | 1843 | 0.510 |
Why?
|
Life Expectancy | 19 | 2011 | 1124 | 0.510 |
Why?
|
Chlamydia trachomatis | 2 | 2006 | 244 | 0.500 |
Why?
|
Chlamydia Infections | 2 | 2006 | 351 | 0.440 |
Why?
|
Hepatitis C, Chronic | 3 | 2007 | 1002 | 0.440 |
Why?
|
Herpes Genitalis | 2 | 2003 | 133 | 0.440 |
Why?
|
Female | 109 | 2012 | 377934 | 0.430 |
Why?
|
Precancerous Conditions | 3 | 2010 | 944 | 0.410 |
Why?
|
Adult | 77 | 2013 | 212470 | 0.410 |
Why?
|
Anti-HIV Agents | 14 | 2011 | 4056 | 0.390 |
Why?
|
Humans | 158 | 2013 | 717280 | 0.380 |
Why?
|
Empirical Research | 1 | 2010 | 116 | 0.380 |
Why?
|
Hepatitis C | 3 | 2004 | 1518 | 0.370 |
Why?
|
Office Visits | 2 | 2006 | 633 | 0.360 |
Why?
|
CD4 Lymphocyte Count | 19 | 2010 | 2526 | 0.360 |
Why?
|
Maternal Health Services | 3 | 2012 | 435 | 0.360 |
Why?
|
Anti-Infective Agents | 3 | 2006 | 938 | 0.360 |
Why?
|
Syphilis, Congenital | 1 | 2008 | 24 | 0.360 |
Why?
|
Guideline Adherence | 2 | 2011 | 2334 | 0.360 |
Why?
|
Cholera Vaccines | 1 | 2011 | 250 | 0.350 |
Why?
|
Antiretroviral Therapy, Highly Active | 10 | 2010 | 1876 | 0.350 |
Why?
|
Program Evaluation | 4 | 2012 | 2535 | 0.340 |
Why?
|
Diagnostic Techniques and Procedures | 2 | 2008 | 202 | 0.340 |
Why?
|
Disease Outbreaks | 2 | 2011 | 1728 | 0.330 |
Why?
|
Viral Vaccines | 2 | 2004 | 635 | 0.330 |
Why?
|
Diagnostic Tests, Routine | 3 | 2004 | 791 | 0.330 |
Why?
|
Models, Statistical | 6 | 2008 | 5032 | 0.310 |
Why?
|
Sensitivity and Specificity | 22 | 2010 | 14904 | 0.310 |
Why?
|
Pelvic Inflammatory Disease | 2 | 2006 | 96 | 0.310 |
Why?
|
United States | 44 | 2013 | 67804 | 0.310 |
Why?
|
Hepatitis B Vaccines | 1 | 2007 | 192 | 0.300 |
Why?
|
Antiviral Agents | 6 | 2007 | 2797 | 0.300 |
Why?
|
Pneumococcal Vaccines | 1 | 2010 | 428 | 0.300 |
Why?
|
Health Services Administration | 1 | 2006 | 63 | 0.290 |
Why?
|
Developed Countries | 1 | 2008 | 403 | 0.290 |
Why?
|
Adolescent | 28 | 2012 | 85143 | 0.280 |
Why?
|
Ribavirin | 2 | 2007 | 394 | 0.280 |
Why?
|
Interferon-alpha | 3 | 2007 | 898 | 0.280 |
Why?
|
Pneumococcal Infections | 1 | 2010 | 549 | 0.270 |
Why?
|
Uterine Cervical Dysplasia | 2 | 2004 | 114 | 0.270 |
Why?
|
Epidemiologic Research Design | 1 | 2008 | 363 | 0.270 |
Why?
|
Cholera | 1 | 2011 | 759 | 0.270 |
Why?
|
Models, Biological | 11 | 2010 | 9892 | 0.270 |
Why?
|
Herpesvirus 2, Human | 2 | 2003 | 180 | 0.260 |
Why?
|
Calibration | 4 | 2009 | 799 | 0.260 |
Why?
|
Adenocarcinoma | 3 | 2013 | 6370 | 0.260 |
Why?
|
Monte Carlo Method | 5 | 2009 | 1306 | 0.250 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2012 | 964 | 0.250 |
Why?
|
Family Planning Services | 3 | 2012 | 238 | 0.240 |
Why?
|
Health Resources | 2 | 2006 | 924 | 0.240 |
Why?
|
Middle Aged | 44 | 2013 | 215054 | 0.240 |
Why?
|
Genital Neoplasms, Female | 1 | 2008 | 510 | 0.240 |
Why?
|
Pneumonia, Pneumocystis | 2 | 2002 | 245 | 0.230 |
Why?
|
Drug Costs | 8 | 2010 | 1158 | 0.230 |
Why?
|
DNA Probes, HPV | 3 | 2008 | 20 | 0.230 |
Why?
|
Pentamidine | 1 | 2002 | 43 | 0.230 |
Why?
|
Hepatitis B | 1 | 2007 | 645 | 0.230 |
Why?
|
Anti-Retroviral Agents | 3 | 2008 | 1602 | 0.230 |
Why?
|
Dapsone | 1 | 2002 | 64 | 0.220 |
Why?
|
Therapeutics | 1 | 2002 | 119 | 0.220 |
Why?
|
Naphthoquinones | 1 | 2002 | 84 | 0.220 |
Why?
|
Antiprotozoal Agents | 1 | 2002 | 91 | 0.220 |
Why?
|
Practice Guidelines as Topic | 4 | 2011 | 7486 | 0.220 |
Why?
|
Oncogene Proteins, Viral | 1 | 2003 | 387 | 0.220 |
Why?
|
Gonorrhea | 1 | 2005 | 308 | 0.210 |
Why?
|
Carcinoma, Squamous Cell | 6 | 2006 | 4038 | 0.210 |
Why?
|
HIV Seropositivity | 2 | 2006 | 897 | 0.210 |
Why?
|
Disease Progression | 14 | 2010 | 13308 | 0.210 |
Why?
|
Prenatal Diagnosis | 1 | 2008 | 1172 | 0.210 |
Why?
|
Pregnancy Outcome | 3 | 2011 | 2703 | 0.210 |
Why?
|
HIV | 4 | 2010 | 1517 | 0.210 |
Why?
|
Time Management | 1 | 2001 | 59 | 0.210 |
Why?
|
Bisexuality | 2 | 2000 | 282 | 0.210 |
Why?
|
Pregnancy | 14 | 2012 | 27304 | 0.200 |
Why?
|
Mass Media | 1 | 2004 | 313 | 0.200 |
Why?
|
Health Education | 3 | 2004 | 1061 | 0.200 |
Why?
|
Women's Health Services | 1 | 2001 | 93 | 0.200 |
Why?
|
Endoscopy | 1 | 2010 | 1758 | 0.190 |
Why?
|
Dilatation and Curettage | 2 | 2010 | 54 | 0.190 |
Why?
|
China | 4 | 2010 | 2282 | 0.190 |
Why?
|
Vacuum Curettage | 2 | 2010 | 48 | 0.190 |
Why?
|
Point-of-Care Systems | 1 | 2008 | 1125 | 0.190 |
Why?
|
Pregnancy Complications, Infectious | 4 | 2011 | 2034 | 0.190 |
Why?
|
Asia | 3 | 2011 | 640 | 0.190 |
Why?
|
Health Status Disparities | 1 | 2011 | 1728 | 0.190 |
Why?
|
Sexually Transmitted Diseases | 2 | 2005 | 566 | 0.190 |
Why?
|
Gambia | 2 | 2010 | 101 | 0.190 |
Why?
|
Abortifacient Agents, Nonsteroidal | 2 | 2010 | 62 | 0.180 |
Why?
|
Primary Prevention | 2 | 2008 | 1152 | 0.180 |
Why?
|
Child | 19 | 2012 | 74388 | 0.180 |
Why?
|
HIV Seronegativity | 1 | 2000 | 207 | 0.180 |
Why?
|
Brazil | 3 | 2007 | 1158 | 0.180 |
Why?
|
Misoprostol | 2 | 2010 | 84 | 0.180 |
Why?
|
Choice Behavior | 2 | 2002 | 797 | 0.180 |
Why?
|
Risk Factors | 21 | 2013 | 70863 | 0.180 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2004 | 628 | 0.180 |
Why?
|
Drug Resistance, Viral | 4 | 2007 | 773 | 0.180 |
Why?
|
Nigeria | 2 | 2012 | 705 | 0.170 |
Why?
|
Smoking | 2 | 2013 | 8948 | 0.170 |
Why?
|
Cesarean Section | 2 | 2004 | 1321 | 0.170 |
Why?
|
Mexico | 3 | 2010 | 679 | 0.170 |
Why?
|
Pharyngeal Neoplasms | 2 | 2008 | 120 | 0.170 |
Why?
|
RNA, Viral | 8 | 2006 | 2837 | 0.170 |
Why?
|
Forecasting | 3 | 2009 | 2948 | 0.160 |
Why?
|
Direct Service Costs | 4 | 2006 | 64 | 0.160 |
Why?
|
Neoplasms | 5 | 2011 | 20572 | 0.160 |
Why?
|
Polyethylene Glycols | 1 | 2003 | 1181 | 0.160 |
Why?
|
Stochastic Processes | 2 | 2008 | 332 | 0.160 |
Why?
|
Incidence | 11 | 2013 | 20654 | 0.160 |
Why?
|
South Africa | 4 | 2009 | 1571 | 0.160 |
Why?
|
Mass Vaccination | 2 | 2008 | 108 | 0.160 |
Why?
|
Decision Trees | 3 | 2009 | 524 | 0.150 |
Why?
|
Delivery of Health Care | 5 | 2013 | 4874 | 0.150 |
Why?
|
Patient Compliance | 2 | 2006 | 2754 | 0.150 |
Why?
|
Cytodiagnosis | 2 | 2004 | 420 | 0.150 |
Why?
|
Streptococcal Infections | 1 | 2001 | 645 | 0.150 |
Why?
|
Physical Examination | 1 | 2002 | 1243 | 0.150 |
Why?
|
Genetic Diseases, Inborn | 1 | 2001 | 596 | 0.150 |
Why?
|
Healthcare Disparities | 1 | 2011 | 3031 | 0.140 |
Why?
|
West Nile Fever | 2 | 2006 | 90 | 0.140 |
Why?
|
Pregnancy Trimester, First | 2 | 2010 | 842 | 0.140 |
Why?
|
Age Factors | 9 | 2009 | 18798 | 0.140 |
Why?
|
Male | 42 | 2013 | 351399 | 0.140 |
Why?
|
Health Services Research | 3 | 2011 | 1837 | 0.140 |
Why?
|
Overweight | 1 | 2006 | 2248 | 0.130 |
Why?
|
Weight Loss | 1 | 2006 | 2495 | 0.130 |
Why?
|
Caribbean Region | 3 | 2008 | 172 | 0.130 |
Why?
|
Uncertainty | 2 | 2010 | 659 | 0.130 |
Why?
|
Vietnam | 3 | 2010 | 395 | 0.130 |
Why?
|
Patient Education as Topic | 1 | 2004 | 2345 | 0.120 |
Why?
|
Cholesterol | 1 | 2002 | 2894 | 0.120 |
Why?
|
Latin America | 3 | 2008 | 352 | 0.120 |
Why?
|
Time Factors | 11 | 2013 | 41094 | 0.120 |
Why?
|
Staphylococcal Infections | 3 | 2001 | 1376 | 0.120 |
Why?
|
Pregnancy Complications | 1 | 2007 | 2830 | 0.120 |
Why?
|
India | 2 | 2010 | 2015 | 0.120 |
Why?
|
Cote d'Ivoire | 3 | 2007 | 52 | 0.120 |
Why?
|
Age Distribution | 4 | 2009 | 2930 | 0.120 |
Why?
|
Quality of Life | 8 | 2008 | 11758 | 0.120 |
Why?
|
Family Planning Policy | 1 | 2012 | 5 | 0.120 |
Why?
|
Risk | 4 | 2009 | 9773 | 0.110 |
Why?
|
Mouth Neoplasms | 2 | 2008 | 609 | 0.110 |
Why?
|
Preventive Medicine | 2 | 2007 | 262 | 0.110 |
Why?
|
Homosexuality, Male | 1 | 2000 | 1151 | 0.110 |
Why?
|
Afghanistan | 1 | 2012 | 82 | 0.110 |
Why?
|
Pacific Islands | 2 | 2008 | 50 | 0.110 |
Why?
|
Africa, Eastern | 1 | 2011 | 70 | 0.110 |
Why?
|
Young Adult | 9 | 2013 | 56249 | 0.110 |
Why?
|
Zimbabwe | 1 | 2011 | 109 | 0.110 |
Why?
|
Infant | 7 | 2011 | 34574 | 0.110 |
Why?
|
Immunity, Herd | 1 | 2011 | 44 | 0.110 |
Why?
|
Health Services Accessibility | 5 | 2012 | 5028 | 0.100 |
Why?
|
Cohort Studies | 13 | 2010 | 39891 | 0.100 |
Why?
|
Acquired Immunodeficiency Syndrome | 4 | 2010 | 2142 | 0.100 |
Why?
|
France | 4 | 2005 | 489 | 0.100 |
Why?
|
Public Health | 4 | 2006 | 2395 | 0.100 |
Why?
|
Air Bags | 3 | 2001 | 12 | 0.100 |
Why?
|
Aged | 20 | 2013 | 162862 | 0.100 |
Why?
|
Costs and Cost Analysis | 3 | 2008 | 1666 | 0.100 |
Why?
|
International Agencies | 1 | 2011 | 242 | 0.100 |
Why?
|
Financial Support | 1 | 2011 | 121 | 0.100 |
Why?
|
Teratogens | 1 | 2011 | 116 | 0.100 |
Why?
|
Ganciclovir | 3 | 2001 | 262 | 0.100 |
Why?
|
Arthroplasty, Replacement, Hip | 1 | 2001 | 1367 | 0.100 |
Why?
|
Insurance Claim Reporting | 1 | 2011 | 168 | 0.100 |
Why?
|
Recombinant Proteins | 3 | 2007 | 6860 | 0.100 |
Why?
|
Peru | 1 | 2012 | 847 | 0.090 |
Why?
|
Marketing of Health Services | 1 | 2011 | 157 | 0.090 |
Why?
|
Directly Observed Therapy | 1 | 2010 | 143 | 0.090 |
Why?
|
Patient Satisfaction | 1 | 2002 | 3402 | 0.090 |
Why?
|
Population Surveillance | 3 | 2010 | 2633 | 0.090 |
Why?
|
Decision Making, Organizational | 2 | 2008 | 135 | 0.090 |
Why?
|
Prevalence | 5 | 2008 | 14899 | 0.090 |
Why?
|
Rotavirus | 1 | 2010 | 113 | 0.090 |
Why?
|
Ghana | 1 | 2010 | 276 | 0.090 |
Why?
|
Benzoxazines | 1 | 2011 | 293 | 0.090 |
Why?
|
Africa | 1 | 2011 | 658 | 0.090 |
Why?
|
Emergency Service, Hospital | 2 | 2007 | 7497 | 0.090 |
Why?
|
Intensive Care, Neonatal | 1 | 2010 | 195 | 0.090 |
Why?
|
Health Expenditures | 3 | 2013 | 2266 | 0.090 |
Why?
|
Health Services Misuse | 1 | 2011 | 242 | 0.090 |
Why?
|
Cytomegalovirus Infections | 3 | 2001 | 762 | 0.090 |
Why?
|
Vaccines, Conjugate | 1 | 2010 | 329 | 0.090 |
Why?
|
Reagent Strips | 1 | 2008 | 38 | 0.090 |
Why?
|
Human papillomavirus 11 | 1 | 2008 | 16 | 0.090 |
Why?
|
Human papillomavirus 6 | 1 | 2008 | 14 | 0.090 |
Why?
|
Genetic Testing | 1 | 2001 | 3340 | 0.090 |
Why?
|
Respiratory Tract Neoplasms | 1 | 2008 | 58 | 0.090 |
Why?
|
Condylomata Acuminata | 1 | 2008 | 82 | 0.090 |
Why?
|
Warts | 1 | 2008 | 70 | 0.080 |
Why?
|
Abnormalities, Drug-Induced | 1 | 2011 | 324 | 0.080 |
Why?
|
Infectious Disease Transmission, Vertical | 3 | 2010 | 1318 | 0.080 |
Why?
|
Health Planning Guidelines | 1 | 2008 | 165 | 0.080 |
Why?
|
Vaccines, Attenuated | 1 | 2009 | 329 | 0.080 |
Why?
|
Drug Therapy, Combination | 6 | 2006 | 6542 | 0.080 |
Why?
|
Colombia | 1 | 2008 | 243 | 0.080 |
Why?
|
Endometrial Neoplasms | 2 | 2007 | 1343 | 0.080 |
Why?
|
Vaginal Neoplasms | 1 | 2008 | 108 | 0.080 |
Why?
|
Papilloma | 1 | 2008 | 155 | 0.080 |
Why?
|
Pregnancy Trimester, Third | 1 | 2010 | 570 | 0.080 |
Why?
|
Microbial Sensitivity Tests | 2 | 2005 | 1920 | 0.080 |
Why?
|
Virology | 2 | 2005 | 74 | 0.080 |
Why?
|
Aged, 80 and over | 7 | 2013 | 58528 | 0.080 |
Why?
|
Risk Assessment | 5 | 2013 | 23543 | 0.080 |
Why?
|
Penile Neoplasms | 1 | 2008 | 159 | 0.080 |
Why?
|
West Nile virus | 1 | 2006 | 81 | 0.070 |
Why?
|
Nutrition Surveys | 1 | 2013 | 1572 | 0.070 |
Why?
|
Risk Reduction Behavior | 1 | 2013 | 1122 | 0.070 |
Why?
|
Communicable Disease Control | 1 | 2013 | 812 | 0.070 |
Why?
|
Health Status Indicators | 2 | 2002 | 987 | 0.070 |
Why?
|
Public Policy | 1 | 2010 | 549 | 0.070 |
Why?
|
Treatment Outcome | 11 | 2010 | 62344 | 0.070 |
Why?
|
Budgets | 2 | 2005 | 217 | 0.070 |
Why?
|
Penicillins | 1 | 2008 | 359 | 0.070 |
Why?
|
False Positive Reactions | 1 | 2008 | 999 | 0.070 |
Why?
|
Africa South of the Sahara | 1 | 2008 | 689 | 0.070 |
Why?
|
Decision Making | 5 | 2008 | 3848 | 0.070 |
Why?
|
Atrioventricular Node | 1 | 2006 | 176 | 0.070 |
Why?
|
Breast Neoplasms | 2 | 2011 | 20086 | 0.070 |
Why?
|
Health Care Rationing | 3 | 2007 | 456 | 0.070 |
Why?
|
Sentinel Surveillance | 1 | 2007 | 292 | 0.070 |
Why?
|
Adolescent Health Services | 1 | 2007 | 216 | 0.070 |
Why?
|
Vulvar Neoplasms | 1 | 2008 | 292 | 0.070 |
Why?
|
Carcinoma | 2 | 2009 | 2325 | 0.070 |
Why?
|
HIV Fusion Inhibitors | 1 | 2005 | 83 | 0.070 |
Why?
|
National Health Programs | 1 | 2008 | 444 | 0.070 |
Why?
|
Immunotherapy, Active | 1 | 2004 | 61 | 0.070 |
Why?
|
Actuarial Analysis | 1 | 2004 | 383 | 0.060 |
Why?
|
Hong Kong | 1 | 2004 | 156 | 0.060 |
Why?
|
Urban Health | 1 | 2007 | 540 | 0.060 |
Why?
|
Child, Preschool | 5 | 2011 | 41221 | 0.060 |
Why?
|
Triage | 2 | 2008 | 928 | 0.060 |
Why?
|
Rape | 1 | 2005 | 131 | 0.060 |
Why?
|
Heart Block | 1 | 2006 | 407 | 0.060 |
Why?
|
Cancer Vaccines | 1 | 2011 | 1004 | 0.060 |
Why?
|
Gynecologic Surgical Procedures | 1 | 2007 | 334 | 0.060 |
Why?
|
Germany | 1 | 2006 | 837 | 0.060 |
Why?
|
Referral and Consultation | 2 | 2008 | 3472 | 0.060 |
Why?
|
Obesity | 1 | 2006 | 12248 | 0.060 |
Why?
|
Health Status | 2 | 2012 | 3995 | 0.060 |
Why?
|
Evidence-Based Practice | 1 | 2008 | 510 | 0.060 |
Why?
|
Anti-Obesity Agents | 1 | 2006 | 202 | 0.060 |
Why?
|
Patient Selection | 2 | 2009 | 4321 | 0.060 |
Why?
|
HIV-1 | 5 | 2007 | 6795 | 0.060 |
Why?
|
Infant, Newborn | 5 | 2010 | 24744 | 0.060 |
Why?
|
Nucleic Acid Amplification Techniques | 1 | 2005 | 299 | 0.060 |
Why?
|
Italy | 1 | 2005 | 806 | 0.060 |
Why?
|
Chemoprevention | 2 | 2002 | 314 | 0.060 |
Why?
|
Epidemiologic Methods | 1 | 2008 | 1366 | 0.060 |
Why?
|
Acetic Acid | 1 | 2002 | 60 | 0.060 |
Why?
|
HIV Envelope Protein gp41 | 1 | 2005 | 321 | 0.060 |
Why?
|
Income | 2 | 2002 | 1805 | 0.060 |
Why?
|
Oropharyngeal Neoplasms | 1 | 2008 | 463 | 0.060 |
Why?
|
Neisseria gonorrhoeae | 1 | 2005 | 236 | 0.060 |
Why?
|
Diet, Reducing | 1 | 2006 | 470 | 0.060 |
Why?
|
Atovaquone | 1 | 2002 | 60 | 0.060 |
Why?
|
Body Constitution | 1 | 2002 | 275 | 0.060 |
Why?
|
Resource Allocation | 1 | 2004 | 343 | 0.060 |
Why?
|
Social Class | 1 | 2011 | 1978 | 0.060 |
Why?
|
Pregnancy, Ectopic | 1 | 2003 | 137 | 0.060 |
Why?
|
Medical Assistance | 1 | 2002 | 99 | 0.050 |
Why?
|
Infant Equipment | 1 | 2001 | 24 | 0.050 |
Why?
|
Massachusetts | 3 | 2011 | 8749 | 0.050 |
Why?
|
Disease-Free Survival | 2 | 2003 | 7056 | 0.050 |
Why?
|
Genotype | 3 | 2007 | 12923 | 0.050 |
Why?
|
Mortality | 1 | 2013 | 2796 | 0.050 |
Why?
|
Social Values | 1 | 2002 | 231 | 0.050 |
Why?
|
Fibrosis | 1 | 2008 | 1964 | 0.050 |
Why?
|
Cost Allocation | 1 | 2001 | 51 | 0.050 |
Why?
|
Seroepidemiologic Studies | 1 | 2002 | 378 | 0.050 |
Why?
|
Cause of Death | 3 | 2010 | 3592 | 0.050 |
Why?
|
Longitudinal Studies | 2 | 2007 | 13613 | 0.050 |
Why?
|
Smoking Cessation | 1 | 2013 | 2045 | 0.050 |
Why?
|
Pelvic Pain | 1 | 2003 | 248 | 0.050 |
Why?
|
Rural Health Services | 1 | 2005 | 379 | 0.050 |
Why?
|
Value of Life | 1 | 2001 | 98 | 0.050 |
Why?
|
Television | 1 | 2004 | 411 | 0.050 |
Why?
|
Heterosexuality | 1 | 2003 | 275 | 0.050 |
Why?
|
Automobiles | 1 | 2001 | 117 | 0.050 |
Why?
|
Netherlands | 1 | 2005 | 2086 | 0.050 |
Why?
|
Condoms | 1 | 2003 | 325 | 0.050 |
Why?
|
Pacemaker, Artificial | 1 | 2006 | 768 | 0.050 |
Why?
|
Vancomycin | 2 | 2001 | 503 | 0.050 |
Why?
|
State Health Plans | 1 | 2002 | 217 | 0.050 |
Why?
|
Women, Working | 1 | 2001 | 84 | 0.050 |
Why?
|
Delivery, Obstetric | 1 | 2007 | 903 | 0.050 |
Why?
|
DNA, Bacterial | 1 | 2005 | 1526 | 0.050 |
Why?
|
Survivors | 1 | 2010 | 2171 | 0.050 |
Why?
|
Insurance, Pharmaceutical Services | 1 | 2002 | 343 | 0.050 |
Why?
|
Cardiovascular Agents | 1 | 2006 | 867 | 0.040 |
Why?
|
Epidemiologic Studies | 1 | 2002 | 637 | 0.040 |
Why?
|
Viral Load | 2 | 2010 | 3242 | 0.040 |
Why?
|
Policy Making | 1 | 2002 | 538 | 0.040 |
Why?
|
Homosexuality | 1 | 1999 | 270 | 0.040 |
Why?
|
Salaries and Fringe Benefits | 1 | 2001 | 271 | 0.040 |
Why?
|
Debridement | 1 | 2001 | 500 | 0.040 |
Why?
|
Educational Status | 2 | 2003 | 2340 | 0.040 |
Why?
|
AIDS Vaccines | 1 | 2004 | 916 | 0.040 |
Why?
|
Survival Analysis | 3 | 2007 | 10542 | 0.040 |
Why?
|
Public Health Practice | 1 | 2000 | 212 | 0.040 |
Why?
|
Mammography | 1 | 2008 | 2475 | 0.040 |
Why?
|
Logistic Models | 2 | 2011 | 13605 | 0.040 |
Why?
|
Peritoneal Dialysis, Continuous Ambulatory | 1 | 1996 | 29 | 0.040 |
Why?
|
Drug Administration Schedule | 2 | 2002 | 5038 | 0.040 |
Why?
|
Infertility, Female | 1 | 2003 | 763 | 0.040 |
Why?
|
Medical Oncology | 1 | 2009 | 2124 | 0.040 |
Why?
|
Cytomegalovirus | 2 | 2001 | 692 | 0.040 |
Why?
|
Appointments and Schedules | 1 | 2001 | 432 | 0.040 |
Why?
|
Posture | 1 | 2001 | 993 | 0.040 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2008 | 2089 | 0.040 |
Why?
|
Defibrillators, Implantable | 1 | 2006 | 1407 | 0.040 |
Why?
|
Safety | 1 | 2001 | 1220 | 0.040 |
Why?
|
Frail Elderly | 1 | 2001 | 609 | 0.040 |
Why?
|
African Americans | 1 | 2011 | 5025 | 0.040 |
Why?
|
Antibiotic Prophylaxis | 1 | 2001 | 631 | 0.040 |
Why?
|
Accidents, Traffic | 1 | 2001 | 805 | 0.040 |
Why?
|
Neoplasm Staging | 3 | 2007 | 11200 | 0.040 |
Why?
|
Biopsy | 1 | 2008 | 6753 | 0.040 |
Why?
|
Air Pollution, Indoor | 1 | 2003 | 893 | 0.040 |
Why?
|
Diagnostic Errors | 1 | 2003 | 1274 | 0.040 |
Why?
|
Medically Uninsured | 1 | 2001 | 865 | 0.030 |
Why?
|
Morbidity | 1 | 2001 | 1706 | 0.030 |
Why?
|
Child Behavior | 1 | 2001 | 829 | 0.030 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2003 | 3968 | 0.030 |
Why?
|
Urban Population | 1 | 2003 | 2025 | 0.030 |
Why?
|
Information Dissemination | 1 | 2004 | 1100 | 0.030 |
Why?
|
Sex Factors | 1 | 2009 | 10661 | 0.030 |
Why?
|
Preventive Health Services | 1 | 2000 | 585 | 0.030 |
Why?
|
Liver Diseases | 1 | 2003 | 1255 | 0.030 |
Why?
|
Health Care Surveys | 1 | 2002 | 2511 | 0.030 |
Why?
|
Polymerase Chain Reaction | 2 | 2001 | 6294 | 0.030 |
Why?
|
Blotting, Western | 1 | 2003 | 5438 | 0.030 |
Why?
|
Rural Population | 1 | 2005 | 2168 | 0.030 |
Why?
|
Peritonitis | 1 | 1996 | 377 | 0.030 |
Why?
|
Attitude to Health | 1 | 2004 | 2102 | 0.030 |
Why?
|
Medicaid | 2 | 2005 | 2636 | 0.030 |
Why?
|
Gynecology | 1 | 1999 | 475 | 0.030 |
Why?
|
Reproducibility of Results | 3 | 2008 | 19537 | 0.030 |
Why?
|
Software | 1 | 2008 | 4367 | 0.030 |
Why?
|
Information Systems | 1 | 1976 | 390 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2010 | 9578 | 0.030 |
Why?
|
Liver Cirrhosis | 1 | 2003 | 1751 | 0.030 |
Why?
|
Body Composition | 1 | 2002 | 2399 | 0.030 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2003 | 3016 | 0.030 |
Why?
|
Genomics | 1 | 2009 | 5338 | 0.030 |
Why?
|
Databases, Factual | 1 | 2008 | 7847 | 0.030 |
Why?
|
Obstetrics | 1 | 1999 | 632 | 0.030 |
Why?
|
Peptide Fragments | 1 | 2005 | 5160 | 0.030 |
Why?
|
Surgical Wound Infection | 1 | 2001 | 1503 | 0.030 |
Why?
|
Colorectal Neoplasms | 1 | 2011 | 6590 | 0.030 |
Why?
|
Coronary Artery Bypass | 1 | 2001 | 2398 | 0.030 |
Why?
|
Adipose Tissue | 1 | 2002 | 3243 | 0.020 |
Why?
|
Alkynes | 1 | 2011 | 312 | 0.020 |
Why?
|
Seat Belts | 2 | 2001 | 64 | 0.020 |
Why?
|
Cyclopropanes | 1 | 2011 | 418 | 0.020 |
Why?
|
Population | 1 | 2009 | 152 | 0.020 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2004 | 3959 | 0.020 |
Why?
|
Spain | 1 | 2010 | 468 | 0.020 |
Why?
|
Recurrence | 1 | 2001 | 8284 | 0.020 |
Why?
|
Cytological Techniques | 1 | 2010 | 219 | 0.020 |
Why?
|
Predictive Value of Tests | 2 | 2001 | 15271 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2007 | 39302 | 0.020 |
Why?
|
Survival Rate | 1 | 2002 | 13262 | 0.020 |
Why?
|
Patient Acceptance of Health Care | 1 | 2002 | 2938 | 0.020 |
Why?
|
American Cancer Society | 1 | 2007 | 62 | 0.020 |
Why?
|
Cross Infection | 1 | 1996 | 1410 | 0.020 |
Why?
|
Liver Neoplasms | 1 | 2002 | 4102 | 0.020 |
Why?
|
Toxoplasmosis, Cerebral | 1 | 2006 | 19 | 0.020 |
Why?
|
International Cooperation | 1 | 2013 | 1420 | 0.020 |
Why?
|
Drug Resistance, Microbial | 2 | 2001 | 875 | 0.020 |
Why?
|
Mycobacterium Infections | 1 | 2006 | 123 | 0.020 |
Why?
|
Isoproterenol | 1 | 2006 | 414 | 0.020 |
Why?
|
Wounds and Injuries | 1 | 1998 | 2416 | 0.020 |
Why?
|
Anti-Bacterial Agents | 2 | 2001 | 7074 | 0.020 |
Why?
|
Georgia | 1 | 2005 | 195 | 0.020 |
Why?
|
Severity of Illness Index | 1 | 2003 | 16020 | 0.020 |
Why?
|
HIV Protease Inhibitors | 1 | 2007 | 429 | 0.020 |
Why?
|
Social Justice | 1 | 2009 | 421 | 0.020 |
Why?
|
Probability | 1 | 2010 | 2489 | 0.020 |
Why?
|
Asthma | 1 | 2003 | 5941 | 0.020 |
Why?
|
Adrenergic beta-Agonists | 1 | 2006 | 360 | 0.020 |
Why?
|
Regression Analysis | 2 | 2006 | 6480 | 0.020 |
Why?
|
Psychiatry | 1 | 1976 | 1618 | 0.020 |
Why?
|
Reverse Transcriptase Inhibitors | 1 | 2007 | 600 | 0.020 |
Why?
|
Blood Donors | 1 | 2006 | 355 | 0.020 |
Why?
|
Hospitalization | 2 | 2001 | 9754 | 0.020 |
Why?
|
Tachycardia | 1 | 2006 | 609 | 0.010 |
Why?
|
Electrophysiologic Techniques, Cardiac | 1 | 2006 | 470 | 0.010 |
Why?
|
Prognosis | 1 | 2004 | 29226 | 0.010 |
Why?
|
Mycoses | 1 | 2006 | 367 | 0.010 |
Why?
|
Haiti | 1 | 2005 | 543 | 0.010 |
Why?
|
Retrospective Studies | 4 | 2006 | 72608 | 0.010 |
Why?
|
Occupations | 1 | 2005 | 511 | 0.010 |
Why?
|
World Health Organization | 1 | 2008 | 1287 | 0.010 |
Why?
|
Pediatric Assistants | 1 | 2001 | 8 | 0.010 |
Why?
|
Gestational Age | 1 | 2010 | 3427 | 0.010 |
Why?
|
Algorithms | 2 | 2002 | 13716 | 0.010 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2007 | 1841 | 0.010 |
Why?
|
Cardiac Pacing, Artificial | 1 | 2006 | 846 | 0.010 |
Why?
|
Continuity of Patient Care | 1 | 2009 | 1048 | 0.010 |
Why?
|
Natural Childbirth | 1 | 2000 | 17 | 0.010 |
Why?
|
Multivariate Analysis | 2 | 2006 | 12484 | 0.010 |
Why?
|
Anti-Arrhythmia Agents | 1 | 2006 | 766 | 0.010 |
Why?
|
Infant, Premature | 1 | 2010 | 2015 | 0.010 |
Why?
|
Cefazolin | 1 | 2001 | 97 | 0.010 |
Why?
|
Disability Evaluation | 1 | 2009 | 1826 | 0.010 |
Why?
|
Multicenter Studies as Topic | 1 | 2006 | 1531 | 0.010 |
Why?
|
Vancomycin Resistance | 1 | 2001 | 130 | 0.010 |
Why?
|
Methicillin Resistance | 1 | 2001 | 202 | 0.010 |
Why?
|
Sexual Partners | 1 | 2005 | 692 | 0.010 |
Why?
|
Sex Distribution | 1 | 2006 | 2369 | 0.010 |
Why?
|
Uterine Cervical Diseases | 1 | 2000 | 79 | 0.010 |
Why?
|
Cephalosporins |